WALK WITH US DISCUSSION FORUMS DONATE NOW
  • English
  • Français
Bladder Cancer CanadaBladder Cancer CanadaBladder Cancer CanadaBladder Cancer Canada
  • ABOUT US
    • Our Mission/Vision
    • Board Of Directors
    • Medical Advisory
      and Research Board
    • Sponsors & Partners
    • Financial Statements and Annual Report
    • Contact Us
  • FACING
    BLADDER CANCER
    • Newly Diagnosed?
    • Canadian Patient Guidebooks
    • Dealing With Emotions
    • Get Support
    • Join a Discussion Forum
    • Videos
    • Webinar Recordings
    • Patient Resources
  • HELPFUL
    INFORMATION
    • Bladder Cancer Facts
    • See Red?
    • Symptoms
    • Bladder Cancer Basics
      • How The Body Works
      • Types of Bladder Cancer
      • Causes
      • Diagnosis
      • Staging and Grading
    • How will my cancer be treated?
      • Nonmuscle Invasive
      • Muscle Invasive
      • Bladder Preservation
      • Metastatic Bladder Cancer
      • Immunotherapy for Bladder Cancer
    • Bladder Removal
      • Diversion Types
      • Common Issues
      • Chemotherapy
      • After Your Surgery
      • At Home
    • Upper Tract Urothelial Carcinoma
    • Palliative Care
    • Doctor Resources
    • Glossary
    • Links
  • STORIES,
    NEWS & EVENTS
    • Latest News & Stories
    • Upcoming Meetings And Events
    • Newsletter Archive
  • RESEARCH and
    CLINICAL TRIALS
    • Canadian Bladder Cancer Information System
    • Clinical Trials
    • BCC Funded Research
    • BCC Research Grant
  • GET
    INVOLVED
    • Canada Walks for Bladder Cancer
    • The Walk Gallery
    • Volunteer
    • Recruiting for Patient Studies
    • Host a Fundraiser
    • Subscribe To Our Newsletter
  • DONATE NOW
    • General Donations
    • Honour & Memorial Donations
    • Planned Giving
    • Securities and Mutual Funds
    • Employer Matching Gifts
    • Donate a Vehicle
    • Where Your Donations Go

Stories, News & Events LATEST NEWS & STORIES
Next

BCC FUNDS FIRST STUDY TO PRODUCE QUALITY INDICATORS FOR BLADDER CANCER

By Tawny Barratt | Latest news and stories | 0 comment | 18 April, 2017 | 0

In 2016 Bladder Cancer Canada funded the first study to comprehensively produce quality indicators for bladder cancer.

Over time these benchmarks will provide the opportunity to improve consistency of care and better outcomes for patients. Though developed in Canada, these indicators can potentially be used around the world.

Read the overview below:

 

No tags.

Related Post

  • Don’t Fit the Profile of the Typical Bladder Cancer Patient?

    By Bladder Cancer Canada | 0 comment

    By Stephen Wilson The average bladder cancer patient is an older male who has smoked, worked with certain chemicals or has a family history of bladder cancer. Does that mean you can’t have bladder cancer?Read more

  • Could a lifelong need for catheterization have led to bladder cancer? 

    By Bladder Cancer Canada | 0 comment

    That’s one topic discussed by Bladder Cancer Canada’s Tawny Barratt and cancer survivor Angela.

  • Jonathan’s First Resection Surgery

    By Bladder Cancer Canada | 0 comment

    We are honored to work with Jonathan to share the story of his bladder cancer diagnosis. Through months of cystoscopies, surgeries and finally, BCG treatments, Jonathan decided to capture the ups and downs of hisRead more

  • When did you see red?

    By Tawny Barratt | 1 comment

    Jonathan remembers the first time he saw blood in his urine. It was his and Mandy’s anniversary. We are honoured to work with Jonathan and his wife, Mandy, to share the story of his bladderRead more

  • “The risk of recurrence of my cancer is high, so I need to take care of myself.”

    By Tawny Barratt | 0 comment

    Read time: 2 minutes We were so pleased to see one of our new Peer Support Volunteers, Gervais  Fournier, featured in this New Normal, Same Cancer news story, seen last month in the Le JournalRead more

  • This May, we’re making bladder cancer impossible to ignore! 

    By Tawny Barratt | Comments are Closed

    Subscribe today! Our May newsletter is filled with lots of initiatives to create awareness for bladder cancer including blogs, podcasts, helpful facts, webinars and more. Bladder cancer is the 5th most common cancer in Canada andRead more

  • Volunteer’s personal approach leads to deeper commitment from corporate supporter

    By Tawny Barratt | 0 comment

    By: Tom Eremondi Read time: 3.5 minutes Admittedly old school, Gerry Ross’ approach to dealing with a local walk sponsor nurtured and enhanced the relationship to a surprising level. This story, however, dates back aboutRead more

  • Bladder cancer & COVID-19 FAQ

    By Tawny Barratt | Comments are Closed

    Uncertain times are upon us, around the world, as we globally respond to the coronavirus (COVID-19) that is affecting us all on some level. Many members of our bladder cancer community are directing questions our way aboutRead more

  • Protecting Yourself During the Coronavirus Outbreak

    By Tawny Barratt | Comments are Closed

    (The following content is sourced from various sites advising on the coronavirus. For more information, please see the end of this article for additional resources. Photo Credit: CDC) As news of the coronavirus (COVID-19) continues toRead more

  • Health Canada Approves BALVERSA

    By Tawny Barratt | Comments are Closed

    In a recent press release, Janssen Pharmaceutical Companies of Johnson & Johnson have announced that they have received approval from Health Canada for BALVERSA™ (erdafitinib), the first FGFR Kinase inhibitor for the treatment of patientsRead more

  • Bladder Cancer Canada receives Charity Intelligence 4-star ranking

    By Tawny Barratt | Comments are Closed

    Bladder Cancer Canada was recently reviewed by Charity Intelligence, an independent organization that researches Canadian charities so that donors can be well informed and give intelligently.  Of the 750 charities that Charity Intelligence has reviewed,Read more

  • BCG (OncoTICE) Supply Update – March 9, 2020

    By Tawny Barratt | Comments are Closed

    IMPORTANT UPDATE – March 9, 2020 Bladder Cancer Canada (BCC) and its Medical Advisory Board were advised by Merck Canada in November 2019 that they would continue to face challenges in the supply of the TICERead more

  • Breaking Barriers in Bladder Cancer Support: Empowering More Canadians 

    By Bladder Cancer Canada | Comments are Closed

    At Bladder Cancer Canada, our mission has always been to provide crucial resources and support to individuals navigating the complexities of bladder cancer. Today, we are thrilled to share a monumental stride towards inclusivity andRead more

  • Patient Highlight: Joanne’s Experience with High-Grade and Invasive Bladder Cancer

    By Bladder Cancer Canada | Comments are Closed

    Joanne was first diagnosed with Carcinoma In Situ, then later with high-grade and invasive bladder cancer – this is her story.

  • Patient Highlight: Florence’s Urostomy Journey

    By Bladder Cancer Canada | Comments are Closed

    Florence is a remarkable 100 and a half-year-old woman living with a urostomy for almost thirty years – this is her story.

  • Patient Highlight: Tim’s Experience with Urothelial Carcinoma

    By Bladder Cancer Canada | Comments are Closed

    Tim was diagnosed at 49 years old – just a couple months shy of his 50th birthday. Here is his story.

  • Patient Highlight: Audrey’s Cancer Journey and Beyond

    By Bladder Cancer Canada | Comments are Closed

    Audrey was diagnosed with bladder cancer in 2017, here is her first-person account of her experience.

Leave a Comment

Cancel reply

Your email address will not be published. Required fields are marked *

Next

Recent Posts

  • Patient Highlight: Reclaiming Life Post Bladder Cancer and Overcoming Challenges with Neo-Bladder, Gladus
  • Breaking Barriers in Bladder Cancer Support: Empowering More Canadians 
  • Patient Highlight: Joanne’s Experience with High-Grade and Invasive Bladder Cancer
  • Patient Highlight: Florence’s Urostomy Journey
  • Patient Highlight: Tim’s Experience with Urothelial Carcinoma

Categories

  • Blog
  • Honouring our volunteers
  • Latest news and stories
  • Patient Stories
  • Uncategorized
  • Upcoming meeting and events

Archives

  • September 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • December 2022
  • October 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • September 2021
  • May 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • December 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • November 2018
  • August 2018
  • June 2018
  • May 2018
  • April 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • August 2017
  • July 2017
  • June 2017
  • April 2017

GET IN TOUCH

Address

4936 Yonge Street
Suite 1000
Toronto, ON M2N 6S3

Charitable Reg No.

83612 6060 RR0001

Phone
1-866-674-8889
Email & Media Contact

info@bladdercancercanada.org

SEND US A MESSAGE
  • Privacy Policy
  • Discussion Forum
  • Contact Us
  • Donate Now
  • ABOUT US
    • Our Mission/Vision
    • Board Of Directors
    • Medical Advisory
      and Research Board
    • Sponsors & Partners
    • Financial Statements and Annual Report
    • Contact Us
  • FACING
    BLADDER CANCER
    • Newly Diagnosed?
    • Canadian Patient Guidebooks
    • Dealing With Emotions
    • Get Support
    • Join a Discussion Forum
    • Videos
    • Webinar Recordings
    • Patient Resources
  • HELPFUL
    INFORMATION
    • Bladder Cancer Facts
    • See Red?
    • Symptoms
    • Bladder Cancer Basics
      • How The Body Works
      • Types of Bladder Cancer
      • Causes
      • Diagnosis
      • Staging and Grading
    • How will my cancer be treated?
      • Nonmuscle Invasive
      • Muscle Invasive
      • Bladder Preservation
      • Metastatic Bladder Cancer
      • Immunotherapy for Bladder Cancer
    • Bladder Removal
      • Diversion Types
      • Common Issues
      • Chemotherapy
      • After Your Surgery
      • At Home
    • Upper Tract Urothelial Carcinoma
    • Palliative Care
    • Doctor Resources
    • Glossary
    • Links
  • STORIES,
    NEWS & EVENTS
    • Latest News & Stories
    • Upcoming Meetings And Events
    • Newsletter Archive
  • RESEARCH and
    CLINICAL TRIALS
    • Canadian Bladder Cancer Information System
    • Clinical Trials
    • BCC Funded Research
    • BCC Research Grant
  • GET
    INVOLVED
    • Canada Walks for Bladder Cancer
    • The Walk Gallery
    • Volunteer
    • Recruiting for Patient Studies
    • Host a Fundraiser
    • Subscribe To Our Newsletter
  • DONATE NOW
    • General Donations
    • Honour & Memorial Donations
    • Planned Giving
    • Securities and Mutual Funds
    • Employer Matching Gifts
    • Donate a Vehicle
    • Where Your Donations Go
Bladder Cancer Canada

×

×

×

×